These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6898640)

  • 1. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
    Kaneko I; Fearon DT; Austen KF
    J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
    [No Abstract]   [Full Text] [Related]  

  • 2. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD; Fearon DT; Austen KF
    J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract]   [Full Text] [Related]  

  • 3. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
    J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple effects of a diamidine (propamidine) on complement activation.
    Vogt W; Hinsch B; Schmidt G; Von Zabern I
    Immunology; 1979 Jan; 36(1):131-7. PubMed ID: 422224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
    Moore FD; Austen KF; Fearon DT
    J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization.
    Kaneko I; Kamoshida K; Takahashi S
    J Antibiot (Tokyo); 1989 Feb; 42(2):236-41. PubMed ID: 2925515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement, a system of recognition of activation and amplification].
    Peltier AP; Kazatchkine MD
    Ann Immunol (Paris); 1982; 133C(2):149-54. PubMed ID: 6921958
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady state relations between control proteins regulating the formation of the alternative pathway C3 convertase.
    Reeve J; Woo PM
    Immunology; 1982 Aug; 46(4):859-66. PubMed ID: 6921154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human complement by heat-killed, human kidney cells grown in cell culture.
    Baker PJ; Osofsky SG
    J Immunol; 1980 Jan; 124(1):81-6. PubMed ID: 6765971
    [No Abstract]   [Full Text] [Related]  

  • 18. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 19. The human alternative complement pathway: biology and immunopathology of activation and regulation.
    Kazatchkine MD; Nydegger UE
    Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of formation of complement C5-convertase].
    Kozlov LV; Lebedeva TV
    Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.